Modified Shock Index to Predict In-Hospital Outcome among Patients Presenting with ST-Segment Elevation Myocardial Infarction

M. Asifudduza, N. Ahmed, Md. Owashak Faysal, Rahatul Quadir, Sharmin Ali, Md Rakibul Hasan, Nurul Islam, S. Sultana
{"title":"Modified Shock Index to Predict In-Hospital Outcome among Patients Presenting with ST-Segment Elevation Myocardial Infarction","authors":"M. Asifudduza, N. Ahmed, Md. Owashak Faysal, Rahatul Quadir, Sharmin Ali, Md Rakibul Hasan, Nurul Islam, S. Sultana","doi":"10.26502/fccm.92920333","DOIUrl":null,"url":null,"abstract":"Background: Prompt identification of higher-risk patients presenting with ST-segment elevation myocardial infarction (STEMI) is crucial to pursue a more aggressive approach. Objective: To evaluate the Modified Shock Index (MSI), as a predictor of in-hospital outcome among patients with STEMI. Methods: This cross sectional observational study was carried out in the Department of Cardiology, National Heart Foundation Hospital and Research Institute, Mirpur, Dhaka from January 2020 to December 2020. A total of 100 patients were selected with acute STEMI admitted in the department of Cardiology, NHFH&RI, within the study period, who fulfilled the inclusion and exclusion criteria. Results: The mean age 55.6±10.2 years in Group I and 56.1±12.0 years in Group II. Male patients were predominant in both the groups. Regarding MSI 40(40.0%) patients had high admission MSI (≥0.91) and 60(60.0%) patients had normal admission MSI (<0.91). Regarding risk factors, hypertension, diabetes mellitus, smoking, dyslipidemia and family H/O CAD were not statistically significant (p>0.05) between the two groups. There was a significant (p<0.05) difference observed for NT-pro-BNP which was higher in group I than group II (77.5% vs 40.0%), but other investigations were not statistically significant (p>0.05) between the two groups. LVEF was found lower in Group I than group II (38.0±4.7 percent vs 42.6±5.2 percent), which was statistically significant (p<0.05) between the two groups. Regarding ECG findings 72.5% of patients were found with anterior MI in group I and 33.3% in group II, which was statistically significant (p<0.05) between the two groups. During the period of hospitalization patients in group I developed heart failure more than group II patients (67.5% vs 26.7%, p value=0.001). Development of cardiogenic shock was also significant in group I patients compared to group II patients (57.5% vs","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology and cardiovascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/fccm.92920333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prompt identification of higher-risk patients presenting with ST-segment elevation myocardial infarction (STEMI) is crucial to pursue a more aggressive approach. Objective: To evaluate the Modified Shock Index (MSI), as a predictor of in-hospital outcome among patients with STEMI. Methods: This cross sectional observational study was carried out in the Department of Cardiology, National Heart Foundation Hospital and Research Institute, Mirpur, Dhaka from January 2020 to December 2020. A total of 100 patients were selected with acute STEMI admitted in the department of Cardiology, NHFH&RI, within the study period, who fulfilled the inclusion and exclusion criteria. Results: The mean age 55.6±10.2 years in Group I and 56.1±12.0 years in Group II. Male patients were predominant in both the groups. Regarding MSI 40(40.0%) patients had high admission MSI (≥0.91) and 60(60.0%) patients had normal admission MSI (<0.91). Regarding risk factors, hypertension, diabetes mellitus, smoking, dyslipidemia and family H/O CAD were not statistically significant (p>0.05) between the two groups. There was a significant (p<0.05) difference observed for NT-pro-BNP which was higher in group I than group II (77.5% vs 40.0%), but other investigations were not statistically significant (p>0.05) between the two groups. LVEF was found lower in Group I than group II (38.0±4.7 percent vs 42.6±5.2 percent), which was statistically significant (p<0.05) between the two groups. Regarding ECG findings 72.5% of patients were found with anterior MI in group I and 33.3% in group II, which was statistically significant (p<0.05) between the two groups. During the period of hospitalization patients in group I developed heart failure more than group II patients (67.5% vs 26.7%, p value=0.001). Development of cardiogenic shock was also significant in group I patients compared to group II patients (57.5% vs
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改良休克指数预测st段抬高型心肌梗死患者的住院预后
背景:及时识别st段抬高型心肌梗死(STEMI)的高危患者对于采取更积极的治疗方法至关重要。目的:评价改良休克指数(MSI)作为STEMI患者住院预后的预测指标。方法:本横断面观察研究于2020年1月至2020年12月在达卡米尔普尔国立心脏基金会医院和研究所心内科进行。选择研究期间在国家卫生与社会科学研究院心内科住院的急性STEMI患者100例,符合纳入和排除标准。结果:ⅰ组患者平均年龄55.6±10.2岁,ⅱ组患者平均年龄56.1±12.0岁。两组患者均以男性为主。MSI方面,两组患者入院时MSI高(≥0.91)者40例(40.0%),入院时MSI正常者60例(60.0%)(0.05)。两组比较差异有统计学意义(p0.05)。I组LVEF低于II组(38.0±4.7% vs 42.6±5.2%),两组比较差异有统计学意义(p<0.05)。心电图表现方面,ⅰ组有72.5%的患者出现前路心肌梗死,ⅱ组为33.3%,两组比较差异有统计学意义(p<0.05)。在住院期间,I组患者发生心力衰竭的比例高于II组(67.5% vs 26.7%, p值=0.001)。与II组患者相比,I组患者发生心源性休克的比例也很显著(57.5% vs
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health. Interaction between Perivascular and Luminal Factors in Arteriovenous Fistula in Yucatan Miniswine. Atrial fibrillation in Retinal Artery Occlusions. Immunomodulation and Thrombolytic Approaches in the Management of Deep Vein Thrombosis and Pulmonary Embolism. Apolipoprotein B in the Risk Assessment, Diagnosis, and Treatment of Cardiometabolic Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1